Pharmaceutical group AstraZeneca has appointed Aradhana Sarin as chief financial officer on Friday, succeeding Marc Dunoyer upon the closing of its acquisition of Alexion Pharmaceuticals on 1 August.
Sarin, currently executive vice-president and CFO Alexion, will relocate from the US to the UK to take over the role held by Dunoyer for more than seven years.
Dunoyer will transition to chief executive of Alexion and chief strategy officer of AstraZeneca.
Chairman Leif Johansson said “On behalf of the board, I’d like to thank Marc for his significant contribution to AstraZeneca’s success since he joined us in 2013. We’re pleased he’s staying with the company, taking on a new senior executive role and look forward to continuing to work with him.
“In Aradhana Sarin, we’ve appointed a talented successor to Marc as an executive director and CFO. The board warmly welcomes her to AstraZeneca.”
As of 0830 BST, AstraZeneca shares were up 0.16% at 7,961.0p.
